Valerie DeBenedette
Valerie DeBenedette is Managing Editor of Drug Topics.
FDA Safety Communication for Ocaliva
FDA Safety Communication for Ocaliva
FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment
A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
Pharmacists Should Have Plans in Place for Disasters
Pharmacists Should Have Plans in Place for Disasters
International pharmacy group says that pharmacists should create advance plans for major disasters.
Limits on Opioid Prescriptions Gain Popularity
Limits on Opioid Prescriptions Gain Popularity
Opioid limits are gaining popularity, but do they actually work?
FDA Recommends Separate Dosing for Kayexalate
Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.
Two OTC Cold Medications Recalled Due to Bacterial Contamination
Mid Valley Pharmaceutical recalls two drugs.
FDA Cracks Down on Regenerative and Stem Cell Therapies
FDA Cracks Down on Regenerative and Stem Cell Therapies
New therapies hold great promise—and great danger.
Walgreens Launches Site for its Outcomes Research Studies
Walgreens Launches Site for its Outcomes Research Studies
New Walgreens website will showcase the chain’s research on adherence and other topics.
Amneal Recalls 13 Lots of Lorazepam Oral
Amneal Recalls 13 Lots of Lorazepam Oral
The provided droppers may have been mislabeled.
Kmart Opens First Telepharmacy with Plans for More
Kmart Opens First Telepharmacy with Plans for More
The first test store in Des Plaines could be just the start.

Poll